Literature DB >> 29808904

Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art.

Leendert Porcelijn1, Elly Huiskes1, Gonda Oldert1, Martin Schipperus2, Jaap J Zwaginga3,4, Masja de Haas1,3,4.   

Abstract

Immune Thrombocytopenia (ITP) is diagnosed by exclusion of other causes for thrombocytopenia. Reliable detection of platelet autoantibodies would support the clinical diagnosis of ITP and prevent misdiagnosis. We optimized our diagnostic algorithm for suspected ITP using the direct monoclonal antibody immobilization of platelet antigens assay (MAIPA), which evaluates the presence of platelet autoantibodies on the glycoproteins (GP) IIb/IIIa, Ib/IX and V bound on the patient platelets. The direct MAIPA was shown to be a valuable technique for the detection of platelet autoantibodies and could possibly become a guide for optimizing therapy towards a more personalized treatment of ITP.
© 2018 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990ITPzzm321990; zzm321990MAIPAzzm321990; Immune thrombocytopenia; autoantibodies

Mesh:

Substances:

Year:  2018        PMID: 29808904     DOI: 10.1111/bjh.15404

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  20 in total

1.  Anti-glycoprotein Ibα autoantibodies do not impair circulating thrombopoietin levels in immune thrombocytopenia patients.

Authors:  Leendert Porcelijn; David E Schmidt; C Ellen van der Schoot; Gestur Vidarsson; Masja de Haas; Rick Kapur
Journal:  Haematologica       Date:  2019-07-11       Impact factor: 9.941

2.  Is the mysterious platelet receptor GPV an unsuspected major target for platelet autoantibodies?

Authors:  Paquita Nurden; Alan T Nurden
Journal:  Haematologica       Date:  2019-06       Impact factor: 9.941

3.  Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia.

Authors:  Sabrina Shrestha; Ishac Nazy; James W Smith; John G Kelton; Donald M Arnold
Journal:  Blood Adv       Date:  2020-07-14

4.  A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia.

Authors:  Hanny Al-Samkari; Rachel P Rosovsky; Rebecca S Karp Leaf; David B Smith; Katayoon Goodarzi; Annemarie E Fogerty; David B Sykes; David J Kuter
Journal:  Blood Adv       Date:  2020-01-14

5.  Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms.

Authors:  David E Schmidt; Katja M J Heitink-Pollé; Annemieke G Laarhoven; Marrie C A Bruin; Barbera Veldhuisen; Sietse Q Nagelkerke; Taco W Kuijpers; Leendert Porcelijn; C Ellen van der Schoot; Gestur Vidarsson; Masja de Haas
Journal:  Blood Adv       Date:  2019-07-09

6.  Case Report: ITP Treatment After CAR-T Cell Therapy in Patients With Multiple Myeloma.

Authors:  Mengyi Du; Linlin Huang; Haiming Kou; Chenggong Li; Yu Hu; Heng Mei
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

7.  Bone marrow remodeling supports hematopoiesis in response to immune thrombocytopenia progression in mice.

Authors:  Oliver J Herd; Gulab Fatima Rani; James P Hewitson; Karen Hogg; Andrew P Stone; Nichola Cooper; David G Kent; Paul G Genever; Ian S Hitchcock
Journal:  Blood Adv       Date:  2021-12-14

8.  Anti-platelet antibodies in childhood immune thrombocytopenia: Prevalence and prognostic implications.

Authors:  David E Schmidt; Katja M J Heitink-Polle; Leendert Porcelijn; C Ellen van der Schoot; Gestur Vidarsson; Marrie C A Bruin; Masja de Haas
Journal:  J Thromb Haemost       Date:  2020-04-12       Impact factor: 5.824

Review 9.  Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments.

Authors:  Sylvain Audia; Matthieu Mahévas; Martin Nivet; Sethi Ouandji; Marion Ciudad; Bernard Bonnotte
Journal:  Hemasphere       Date:  2021-06-01

Review 10.  A Review of Romiplostim Mechanism of Action and Clinical Applicability.

Authors:  James B Bussel; Gerald Soff; Adriana Balduzzi; Nichola Cooper; Tatiana Lawrence; John W Semple
Journal:  Drug Des Devel Ther       Date:  2021-05-26       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.